ALLO - Allogene Therapeutics Inc. (ALLO) CEO David Chang on Q4 2020 Results - Earnings Call Transcript

Allogene Therapeutics, Inc. (ALLO) Q4 2020 Earnings Conference Call February 25, 2021 5:00 PM ET Company Participants Christine Cassiano - Chief Communications Officer David Chang - President and Chief Executive Officer Rafael Amado - Executive Vice President-Research and Development and Chief Medical Officer Eric Schmidt - Chief Financial Officer Conference Call Participants Biren Amin - Jefferies Marc Frahm - Cowen & Company Tyler Van Buren - Piper Sandler Michael Schmidt - Guggenheim John Newman - Canaccord Mark Breidenbach - Oppenheimer Lisa Walter - RBC Ren Benjamin - JMP Securities Carolina Ibanez - Stifel Sadia Rahman - Bank of America Raju Prasad - William Blair Asthika Goonewardene - Truist Securities Presentation Operator Good afternoon, ladies and gentlemen. Thank you for standing by, and welcome to the Allogene Therapeutics Fourth Quarter and Year-end 2020 Conference Call. At this time all participants are in a listen-only mode. After the speakers' presentation there will

For further details see:

Allogene Therapeutics, Inc. (ALLO) CEO David Chang on Q4 2020 Results - Earnings Call Transcript